These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36467553)

  • 1. The Efficacy and Safety of Zaoren Anshen Capsule in Combination with Zolpidem for Insomnia: A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Trial.
    Zhu X; Tao M; Hu H; Gao J; Chen J; Lu T; Wang X; Kong W; Lv L; Wei M
    Evid Based Complement Alternat Med; 2022; 2022():5867523. PubMed ID: 36467553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on efficacy of zaoren anshen capsules in treating senile insomnia and changes in its hemorheology].
    Gan JG; Tian GQ; Qin GX
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):273-5. PubMed ID: 23672055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Network Meta-analysis of efficacy and safety of Chinese patent medicines in treatment of insomnia].
    Shi ML; Zhao M; Wang YH; Sun TY; Li XL; Ren F; Bian SB; Cui ZH; Li SS
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5403-5417. PubMed ID: 34738444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings.
    Inoue Y; Nishida M; Kubota N; Koebis M; Taninaga T; Muramoto K; Ishikawa K; Moline M
    J Clin Sleep Med; 2023 Mar; 19(3):519-528. PubMed ID: 36472134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Designed Ningxin Anshen Formula for Treatment of Post-ischemic Stroke Insomnia: A Randomized Controlled Trial.
    Dai N; Li Y; Sun J; Li F; Xiong H
    Front Neurol; 2020; 11():537402. PubMed ID: 33240190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial.
    Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y
    BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder.
    Moline M; Zammit G; Cheng JY; Perdomo C; Kumar D; Mayleben D
    J Clin Sleep Med; 2021 Jun; 17(6):1167-1174. PubMed ID: 33590823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial.
    Xiang T; Cai Y; Hong Z; Pan J
    Sleep Med; 2021 Nov; 87():250-256. PubMed ID: 34688027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zao Ren An Shen capsule for insomnia: a double-blind, randomized, placebo-controlled trial.
    Birling Y; Zhu X; Avard N; Tannous C; Fahey PP; Sarris J; Bensoussan A
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34788454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Zaoren Anshen capsules in the treatment of insomnia: A meta-analysis of randomized controlled trials.
    Chen BW; Yi J; Sun B; Jia P; Zhang WJ; Liu BY
    Medicine (Baltimore); 2020 Feb; 99(6):e19033. PubMed ID: 32028417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
    Dockhorn RJ; Dockhorn DW
    Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
    Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.